Search research articles
Contact Us
Filters
Showing results (601-610 of 917) with videos related to
Page
of 92
Sort By:
Toxicology
|
September 7, 2010
Evaluation of a urinary kidney biomarker panel in rat models of acute and subchronic nephrotoxicity
Dana Hoffmann, Tobias C Fuchs, Tanja Henzler, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 1980
Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin
R N Jones, P C Fuchs, H M Sommers, et al.
Diagnostic Microbiology and Infectious Disease
|
July 1, 1991
Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6000 recent clinical isolates from five medical centers
R N Jones, M A Pfaller, S D Allen, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
April 18, 2002
Role of ET-1 receptor binding and [Ca(2+)](i) in contraction of coronary arteries from DOCA-salt hypertensive rats
Ararat D Giulumian, Mariela M Molero, Vikram B Reddy, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
August 1, 1992
Comparison of fixed concentration and fixed ratio options for testing susceptibility of gram-negative bacilli to piperacillin and piperacillin/tazobactam
M A Pfaller, A L Barry, P C Fuchs, et al.
Diagnostic Microbiology and Infectious Disease
|
November 1, 1986
In vitro activity of carumonam (RO 17-2301), BMY-28142, aztreonam, and ceftazidime against 7,620 consecutive clinical bacterial isolates
P C Fuchs, R N Jones, A L Barry, et al.
Investigational New Drugs
|
January 1, 1996
Phase II trial of ZD1694 (Tomudex) in patients with advanced pancreatic cancer
R Pazdur, N J Meropol, E S Casper, et al.
The Journal of Antimicrobial Chemotherapy
|
February 1, 1996
In-vitro susceptibility of Streptococcus pneumoniae to the d- and l-isomers of ofloxacin: interpretive criteria and quality control limits
A L Barry, P C Fuchs, S D Allen, et al.
The Journal of Antimicrobial Chemotherapy
|
November 1, 1995
Tests for susceptibility of Streptococcus pneumoniae to cefdinir: proposed interpretive criteria and quality control parameters for both microdilution and disc diffusion methods
P C Fuchs, A L Barry, F C Tenover, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
February 9, 2002
Potassium (BK(Ca)) currents are reduced in microvascular smooth muscle cells from insulin-resistant rats
Christiana Dimitropoulou, Guichun Han, Allison W Miller, et al.
Page
of 92
Search research articles
Search
Showing results (601-610 of 917) with videos related to
Sort By:
Page
of 92
Toxicology
|
September 7, 2010
Evaluation of a urinary kidney biomarker panel in rat models of acute and subchronic nephrotoxicity
Dana Hoffmann, Tobias C Fuchs, Tanja Henzler, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 1980
Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin
R N Jones, P C Fuchs, H M Sommers, et al.
Diagnostic Microbiology and Infectious Disease
|
July 1, 1991
Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6000 recent clinical isolates from five medical centers
R N Jones, M A Pfaller, S D Allen, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
April 18, 2002
Role of ET-1 receptor binding and [Ca(2+)](i) in contraction of coronary arteries from DOCA-salt hypertensive rats
Ararat D Giulumian, Mariela M Molero, Vikram B Reddy, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
August 1, 1992
Comparison of fixed concentration and fixed ratio options for testing susceptibility of gram-negative bacilli to piperacillin and piperacillin/tazobactam
M A Pfaller, A L Barry, P C Fuchs, et al.
Diagnostic Microbiology and Infectious Disease
|
November 1, 1986
In vitro activity of carumonam (RO 17-2301), BMY-28142, aztreonam, and ceftazidime against 7,620 consecutive clinical bacterial isolates
P C Fuchs, R N Jones, A L Barry, et al.
Investigational New Drugs
|
January 1, 1996
Phase II trial of ZD1694 (Tomudex) in patients with advanced pancreatic cancer
R Pazdur, N J Meropol, E S Casper, et al.
The Journal of Antimicrobial Chemotherapy
|
February 1, 1996
In-vitro susceptibility of Streptococcus pneumoniae to the d- and l-isomers of ofloxacin: interpretive criteria and quality control limits
A L Barry, P C Fuchs, S D Allen, et al.
The Journal of Antimicrobial Chemotherapy
|
November 1, 1995
Tests for susceptibility of Streptococcus pneumoniae to cefdinir: proposed interpretive criteria and quality control parameters for both microdilution and disc diffusion methods
P C Fuchs, A L Barry, F C Tenover, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
February 9, 2002
Potassium (BK(Ca)) currents are reduced in microvascular smooth muscle cells from insulin-resistant rats
Christiana Dimitropoulou, Guichun Han, Allison W Miller, et al.
Page
of 92